2016
DOI: 10.3109/14756366.2016.1144593
|View full text |Cite
|
Sign up to set email alerts
|

Molecular dynamic simulations and structure-based pharmacophore development for farnesyltransferase inhibitors discovery

Abstract: Farnesyltransferase is one of the enzyme targets for the development of drugs for diseases, including cancer, malaria, progeria, etc. In the present study, the structure-based pharmacophore models have been developed from five complex structures (1LD7, 1NI1, 2IEJ, 2ZIR and 2ZIS) obtained from the protein data bank. Initially, molecular dynamic (MD) simulations were performed for the complexes for 10 ns using AMBER 12 software. The conformers of the complexes (75) generated from the equilibrated protein were un… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 43 publications
0
5
0
Order By: Relevance
“…The last 90 ns of the simulation were considered for hydrogen bonding analysis, and cluster analysis of the conformations was generated. This overall procedure has been previously used with success in the treatment of several biomolecular systems [49][50][51][52][53][54][55][56][57].…”
Section: Molecular Dynamics Simulations and Free Energy Calculationsmentioning
confidence: 99%
“…The last 90 ns of the simulation were considered for hydrogen bonding analysis, and cluster analysis of the conformations was generated. This overall procedure has been previously used with success in the treatment of several biomolecular systems [49][50][51][52][53][54][55][56][57].…”
Section: Molecular Dynamics Simulations and Free Energy Calculationsmentioning
confidence: 99%
“…This overall procedure has been previously used with success in the treatment of several biomolecular systems. 51–59…”
Section: Methodsmentioning
confidence: 99%
“…FTIs are a kind of anticancer reagents targeting tumor cell signal transduction pathways [17,18]. They can inhibit the farnesylation of many proteins including Ras to exert the antitumor effect [1].…”
Section: Discussionmentioning
confidence: 99%